IMR Press / FBL / Volume 8 / Issue 6 / DOI: 10.2741/1127

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

BRCA proteins and DNA damage checkpoints
Show Less
1 Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA
Front. Biosci. (Landmark Ed) 2003, 8(6), 718–721;
Published: 1 May 2003

BRCA1 and BRCA2 are frequently mutated in breast cancer patients, responsible for the majority cases of familial breast cancer. Through genetic and biochemical analysis, the function of BRCA1 and BRCA2 is emerging. This review examines recent progresses in understanding the roles of BRCA proteins in DNA damage checkpoint control and how they are regulated in response to DNA damage.

Back to top